OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
June 15, 2017
Congressional measures lack the support to move forward.
June 02, 2017
Approval of breakthrough therapies requires expedited quality assessment.
May 09, 2017
FDA hopes to better use global resources and avoid duplicate inspections of foreign facilities.
User fee reauthorizations, a hiring freeze, and opioid epidemic await the new FDA commissioner Scott Gottlieb.
May 02, 2017
Recent legislation and PDUFA initiatives aim to streamline oversight and testing requirements.
April 06, 2017
The role of patient advocates in shaping regulations and policy has put attention on financial and operational links between drug companies and independent health organizations.